282
Views
1
CrossRef citations to date
0
Altmetric
Review

An Update on the Outcomes of Patients Treated with Urolift for Benign Prostatic Hyperplasia

, , &
Pages 347-355 | Published online: 11 Jun 2021

References

  • Lepor H. Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol. 2004;6(Suppl9):S3–s10.
  • Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015;22(Suppl 1):1–6.
  • Robertson C, Link CL, Onel E, et al. The impact of lower urinary tract symptoms and comorbidities on quality of life: the BACH and UREPIK studies. BJU Int. 2007;99(2):347–354. doi:10.1111/j.1464-410X.2007.06609.x
  • Novara G, Galfano A, Gardi M, Ficarra V, Boccon-Gibod L, Artibani W. Critical review of guidelines for BPH diagnosis and treatment strategy. Eur Urol Supplements. 2006;5(4):418–429. doi:10.1016/j.eursup.2006.02.005
  • Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH. Eur Urol. 2006;49(6):970–978. doi:10.1016/j.eururo.2005.12.072
  • Emberton M, Fitzpatrick JM, Rees J. Risk stratification for benign prostatic hyperplasia (BPH) treatment. BJU Int. 2011;107(6):876–880. doi:10.1111/j.1464-410X.2010.10041.x
  • Geavlete P. Is classical transurethral resection of the prostate, the gold standard endoscopic treatment for benign prostate hyperplasia, in real danger of being replaced? Eur Urol. 2010;58(3):356. doi:10.1016/j.eururo.2010.06.001
  • Magistro G, Stief CG, Gratzke C. New intraprostatic injectables and prostatic urethral lift for male LUTS. Nat Rev Urol. 2015;12(8):461–471. doi:10.1038/nrurol.2015.169
  • Pushkaran A, Stainer V, Muir G, Shergill IS. Urolift - minimally invasive surgical BPH management. Expert Rev Med Devices. 2017;14(3):223–228. doi:10.1080/17434440.2017.1296762
  • Jones P, Rai BP, Aboumarzouk O, Somani BK. UroLift: a new minimally-invasive treatment for benign prostatic hyperplasia. Ther Adv Urol. 2016;8(6):372–376. doi:10.1177/1756287216671497
  • Lebdai S, Chevrot A, Doizi S, et al. Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment. World J Urol. 2019;37(2):299–308. doi:10.1007/s00345-018-2368-6
  • Bouhadana D, Nguyen DD, Zorn KC, Elterman DS, Bhojani N. Patient perspectives on benign prostatic hyperplasia surgery: a focus on sexual Health. J Sex Med. 2020;17(10):2108–2112.
  • Perera M, Roberts MJ, Doi SA, Bolton D. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. Eur Urol. 2015;67(4):704–713. doi:10.1016/j.eururo.2014.10.031
  • Barkin J, Giddens J, Incze P, Casey R, Richardson S, Gange S. UroLift system for relief of prostate obstruction under local anesthesia. Can J Urol. 2012;19(2):6217–6222.
  • Haltbakk J, Hanestad BR, Hunskaar S. How important are men’s lower urinary tract symptoms (LUTS) and their impact on the quality of life (QOL)? Qual Life Res. 2005;14(7):1733–1741. doi:10.1007/s11136-005-3232-x
  • Roehrborn CG, Gange SN, Shore ND, et al. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the. L I F T Study J Urol. 2013;190(6):2161–2167.
  • Roehrborn CG, Barkin J, Gange SN, et al. Five year results of the prospective randomized controlled prostatic urethral. L I F T Study Can J Urol. 2017;24(3):8802–8813.
  • Rukstalis D, Grier D, Stroup SP, et al. Prostatic Urethral Lift (PUL) for obstructive median lobes: 12 month results of the MedLift Study. Prostate Cancer Prostatic Dis. 2019;22(3):411–419. doi:10.1038/s41391-018-0118-x
  • Shah BB, Tayon K, Madiraju S, Carrion RE, Perito P. Prostatic Urethral Lift: does size matter? J Endourol. 2018;32(7):635–638. doi:10.1089/end.2017.0855
  • Rukstalis D, Rashid P, Bogache WK, et al. 24‐month durability after crossover to the prostatic urethral lift from randomised, blinded sham. BJU Int. 2016;118:14–22. doi:10.1111/bju.13666
  • Gratzke C, Barber N, Speakman MJ, et al. Prostatic urethral lift vs transurethral resection of the prostate: 2‐year results of the BPH 6 prospective, multicentre, randomized study. BJU Int. 2017;119(5):767–775. doi:10.1111/bju.13714
  • Al-Singary W, Patel R, Obi-Njoku O, Patel HRH. The UroLift System for lower urinary tract obstruction: patient selection for optimum clinical outcome. Minim Invasive Ther Allied Technol. 2020;1–6. doi:10.1080/13645706.2020.1816554
  • Sievert KD, Schonthaler M, Berges R, et al. Minimally invasive prostatic urethral lift (PUL) efficacious in TURP candidates: a multicenter German evaluation after 2 years. World J Urol. 2019;37(7):1353–1360. doi:10.1007/s00345-018-2494-1
  • Eure G, Gange S, Walter P, et al. Real-World evidence of prostatic urethral lift confirms pivotal clinical study results: 2-year outcomes of a retrospective multicenter study. J Endourol. 2019;33(7):576–584. doi:10.1089/end.2019.0167
  • Kim JH, Lee KS, Kim TH. Evaluation of clinical outcomes of prostatic urethral lift for benign prostatic hyperplasia: an asian population study. World J Mens Health. 2020;38(3):338–344. doi:10.5534/wjmh.190015
  • Tutrone RF, Schiff W. Early patient experience following treatment with the UroLift prostatic urethral lift and Rezum steam injection. Can J Urol. 2020;27(3):10213–10219.
  • Tanneru K, Jazayeri SB, Alam MU, et al. An indirect comparison of newer minimally invasive treatments for benign prostatic hyperplasia: a network meta-analysis model. J Endourol. 2021;35(4):409–416. doi:10.1089/end.2020.0739
  • Tanneru K, Gautam S, Norez D, et al. Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia. Int Urol Nephrol. 2020;52(6):999–1008. doi:10.1007/s11255-020-02408-y
  • Magistro G, Stief CG, Woo HH. Mini-review: what is new in urolift? Eur Urol Focus. 2018;4(1):36–39. doi:10.1016/j.euf.2018.01.013